Bacterial outer membrane vesicles in immune modulation: from mechanisms to applications

Area of Science:

• Immunology
• Microbiology
• Biotechnology

Background:

• Outer membrane vesicles (OMVs) are naturally released by Gram-negative bacteria.
• OMVs possess inherent immunogenicity and are amenable to engineering for therapeutic applications.

Purpose of the Study:

• To review the mechanisms by which OMVs activate and regulate innate and adaptive immunity.
• To explore the engineered applications of OMVs as vaccine platforms and drug delivery systems.
• To highlight the potential of OMVs in cancer treatment and infectious disease prevention.

Main Methods:

• Literature review of studies on OMV-mediated immune responses.
• Analysis of OMV interactions with immune receptors (e.g., Toll-like receptors).
• Examination of OMV engineering strategies for antigen and drug delivery.

Main Results:

• OMVs stimulate innate immunity via immune receptor engagement and inflammatory pathways.
• OMVs facilitate adaptive immunity by delivering antigens to dendritic cells, promoting T-cell activation and antibody production.
• Engineered OMVs show potential as customizable vaccine carriers and targeted drug delivery vehicles, reducing toxicity.

Conclusions:

• OMVs exhibit dual utility as natural immunostimulants and engineered therapeutics.
• Understanding OMV-driven immune mechanisms is crucial for clinical translation.
• OMVs represent a promising avenue for immune engineering in cancer therapy and infection control.